Previously, it has been reported that the hazard rate for tumor relapse of estrogen receptor (ER)-positive and ER-negative tumors displays a bimodal curve with a first, dominant early peak and a second, lower later surge followed by a long-lasting “tail” (20). The gene discussed is ESR1; the disease is neoplasm.